Innovative Market Access Strategies for Medical Devices & Technologies

Event Overview

Increasing national healthcare budgetary pressures, are forcing manufacturers to think out of the box and implement more innovative reimbursement models and value-based schemes. Demonstrating product value with data that really counts in payers', regulators' and other stakeholders' decision-making processes, is essential in order to gain and retain access in key markets.

Budgetary pressures however, could also present an opportunity to the medical devices industry. Many payers are considering, now more then ever, to allocate more funds towards surgical interventions involving devices instead of long-term drug treatments. Market access experts must be able to demonstrate value real evidence-based data for the long-term in order to convince payers that choosing drug therapies may actually cost them more.

As well as the more established markets, market access in European emerging economies (i.e. CEE and Russia) is often delayed and restricted by lack of transparency and predictability. Approaching those markets requires specific adjustments based on local knowledge, and an excellent understanding of multi-stakeholder needs and initiatives in order to take advantage of those markets' potential.

The dynamic macro-economic environment offers both opportunities and challenges which will be discussed during our unique 2 day event. This meeting for senior directors will present the latest cutting-edge case studies and methodologies from leading industry experts and will bring payers & leading academics to the discussion to ensure that the complete picture is understood, the key issues are clarified and networking opportunities are maximised.

Why attend?

• Understand how payers evaluate evidence-based data and what defines value.
• Discover how pricing & reimbursement decisions are made and based on what criteria.
• Learn how health technology assessment for medical devices is evolving in key markets.
• Know more about how HTA evaluation in pharmaceuticals is effecting decision making for medical devices.
• View the complete global picture: payers, industry leaders and academia.
• Gain access to industry case-studies to obtain information on latest market access strategies & models.
• Map and manage stakeholder relations in complex markets and overcome the barriers they present.

Who will benefit:

Device manufacturers & distributors:
Marketing (global, European and local-level), market-access, business development, country managers, health economics, pricing & reimbursement, government & stakeholder relations.

Non-industry stakeholders:
Officials from health ministries, health insurance providers and hospitals, Surgeons and academics.

Your Prestigious Speaker Panel

A more detailed list of speakers’ names is available on the downloadable agenda. Please „request event agenda“ below.